Envoy Medical (COCH) Liabilities and Shareholders Equity (2020 - 2026)

Envoy Medical has disclosed Liabilities and Shareholders Equity across 7 years of filings, most recently posting $23.9 million for Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity rose 141.91% year-over-year to $23.9 million; the TTM figure through Jun 2026 stood at $70.5 million (up 71.06% YoY), while the FY2025 annual figure was $8.6 million, down 25.83% from the prior year.
• Liabilities and Shareholders Equity came in at $23.9 million for Q2 2026 at Envoy Medical, down from $29.8 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $427.8 million in Q3 2022 to a low of $2.6 million in Q4 2022.
• Average Liabilities and Shareholders Equity over 5 years is $86.7 million, with a median of $11.0 million recorded in 2024.
• Year-over-year, Liabilities and Shareholders Equity slumped 99.4% in 2022 and jumped 223.59% in 2023.
• Over 5 years, Liabilities and Shareholders Equity stood at $2.6 million in 2022, then jumped by 223.59% to $8.3 million in 2023, then soared by 39.5% to $11.5 million in 2024, then retreated by 25.83% to $8.6 million in 2025, then surged by 179.84% to $23.9 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $23.9 million in Q2 2026, $29.8 million in Q1 2026, and $8.6 million in Q4 2025.